Newcells Biotech is based at the world-renowned Centre for Life in Newcastle-Upon-Tyne, UK. The company was founded in 2014 as a spin out biotechnology company from Newcastle University. The company...
Newcells Biotech is based at the world-renowned Centre for Life in Newcastle-Upon-Tyne, UK. The company was founded in 2014 as a spin out biotechnology company from Newcastle University. The company is founded on the technology and expertise of one of the UK's leading centres for stem cell biology and located alongside one of the largest research-intensive medical university and hospital complexes in the UK. NEW THINKING Human induced pluripotent stem cell (hiPSC) lines are fast becoming instrumental in advances in disease modelling, drug development and drug toxicity. By delivering the "best in biology" human tissue samples and converting these lines into specific cell types, we can significantly improve the unpredictable and costly global drug discovery process. NEW APPROACHES Using our hiPSC and cell biology technology, we create differentiated cells and incorporate them into novel pre-clinical assays covering both human and other key species. NEW OPPORTUNITIES We have the expertise to collaborate with multidisciplinary teams in industry and academia. We are experts in developing cells of the retina, kidney, immune system and skin – making not just simple models, but complex miniature organs to mimic in-vivo human physiology. NEW DISCOVERIES Working with ethically sourced patient samples we can build in-vitro models of diseases to accelerate exploration of targets and new chemical entities.
Founded Year
2015
Organization Website
newcellsbiotech.co.uk
Organization Languages
English
Organization Revenue
2400
Current Technologies
123-reg dns
apache
google analytics
mobile friendly
Job Functions
Information Technology
sourcing samples for human disease cell lines
induced pluripotent stem cells
cellular reprogramming & differentiation
human ipsc derived cardiomyocytes & neurons for toxicity testing